Jie Shen
Kunming University of Science and Technology(CN)Nanjing University of Chinese Medicine(CN)Central South University(CN)Wenzhou Medical University(CN)AbbVie (United States)(US)First People's Hospital of Yunnan Province(CN)Ruian People's Hospital(CN)Nanjing Drum Tower Hospital(CN)Hunan Cancer Hospital(CN)Jiangsu Hengrui Medicine (China)(CN)Jiangsu Province Hospital(CN)Third Xiangya Hospital(CN)Zhejiang University(CN)Nanjing Medical University(CN)
Publications by Year
Research Areas
Lung Cancer Research Studies, RNA modifications and cancer, Epigenetics and DNA Methylation, Cancer Immunotherapy and Biomarkers, Cholangiocarcinoma and Gallbladder Cancer Studies
Most-Cited Works
- → Chimeric antigen receptor macrophage therapy for breast tumours mediated by targeting the tumour extracellular matrix(2019)273 cited
- → Targeted delivery of miR-200c/DOC to inhibit cancer stem cells and cancer cells by the gelatinases-stimuli nanoparticles(2013)126 cited
- → Prognostic value of pretreatment prognostic nutritional index in non-small cell lung cancer: A systematic review and meta-analysis(2018)75 cited
- → Prognostic Value of Serum Lactate Dehydrogenase in Renal Cell Carcinoma: A Systematic Review and Meta-Analysis(2016)51 cited
- → Postoperative Pneumonia in Geriatric Patients With a Hip Fracture: Incidence, Risk Factors and a Predictive Nomogram(2022)44 cited
- → A phase II FOLFOX-4 regimen as second-line treatment in advanced biliary tract cancer refractory to gemcitabine/cisplatin(2013)